within Pharmacolibrary.Drugs.S_SensoryOrgans.S01H_LocalAnesthetics.S01HA04_Proxymetacaine;

model Proxymetacaine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.75e-05,
    adminDuration = 600,
    adminMass = 0.5 / 1000000,
    adminCount = 1,
    Vd = 5e-05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Proxymetacaine</td></tr><tr><td>ATC code:</td><td>S01HA04</td></tr><td>route:</td><td>ophthalmic</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.05</td><td>L</td></tr>
    <tr><td>clearance:</td><td>15</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Proxymetacaine (also known as proparacaine) is a topical local anesthetic primarily used in ophthalmology to anesthetize the surface of the eye during procedures such as tonometry, removal of foreign bodies, or minor surgical interventions. It is approved for clinical use in various countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical ophthalmic administration in adults, as no published PK studies for proxymetacaine in humans could be identified.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.S.S01HA04 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Proxymetacaine;
